CEPI: Accelerating Lassa Fever Vaccine Development in Nigeria
4 Mins read
The law of inertia, referred to as Newton’s first law of motion, states that “an object will remain at rest or in…
CEPI and IVI collaborate on clinical research to expand access to COVID-19 vaccines in Africa
4 Mins read
July 20, 2021; Oslo, Norway and Seoul, Republic of Korea: The Coalition for Epidemic Preparedness Innovations (CEPI) and the International Vaccine Institute (IVI)…
EDCTP and CEPI funding moves IAVI's Lassa fever vaccine candidate into advanced clinical development
4 Mins read
Global consortium of expert partners will generate proof-of-concept data to support product licensure and future access NEW YORK, THE HAGUE, AND OSLO…
CEPI and the African Union join forces to boost African vaccine R&D and manufacturing
3 Mins read
Oslo, Norway, and Addis Ababa, Ethiopia; April 13, 2021—The Coalition for Epidemic Preparedness Innovations (CEPI) and the African Union Commission have today…
Themis Bioscience and CEPI Announce Initiation of Phase 1 Clinical Trial with Lassa Fever Vaccine
4 Mins read
Coalition for Epidemic Preparedness Innovations (CEPI) partnership will support Themis’ development and manufacturing of vaccine candidate — Vienna, Austria and Oslo, Norway,…